questionsmedicales.fr
Lipides
Acides gras
Acides gras insaturés
Acides gras indispensables
Acides arachidoniques
Thromboxanes
Thromboxane B2
Thromboxane B2 : Questions médicales fréquentes
Diagnostic
5
Thromboxane B2
Tests de laboratoire
Thromboxane B2
Agrégation plaquettaire
Biomarqueurs
Thromboxane B2
Symptômes
Troubles de la coagulation
Maladies cardiovasculaires
Thromboembolie
Symptômes
5
Douleur thoracique
Accident vasculaire cérébral
Thromboxane B2
Pathologies
Vasoconstriction
Circulation sanguine
Prévention
5
Prévention
Mode de vie sain
Gestion du stress
Thromboxane B2
Examens médicaux
Détection précoce
Hydratation
Circulation sanguine
Traitements
5
Anti-inflammatoires
Thromboxane B2
Prévention
Événements cardiovasculaires
Effets secondaires
Saignements
Complications
5
Thromboses
Accident vasculaire cérébral
Maladies cardiaques
Thromboxane B2
Accident vasculaire cérébral
Caillots sanguins
Complications chirurgicales
Thromboembolie
Saignements
Thromboembolie
Facteurs de risque
5
Âge
Changements métaboliques
Stress
Risque cardiovasculaire
Antécédents familiaux
Maladies cardiovasculaires
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Thromboxane B2 : Questions médicales les plus fréquentes",
"headline": "Thromboxane B2 : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Thromboxane B2 : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-01-11",
"dateModified": "2026-03-31",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Thromboxane B2"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Thromboxanes",
"url": "https://questionsmedicales.fr/mesh/D013931",
"about": {
"@type": "MedicalCondition",
"name": "Thromboxanes",
"code": {
"@type": "MedicalCode",
"code": "D013931",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D10.251.355.310.166.971"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Thromboxane B2",
"alternateName": "Thromboxane B2",
"code": {
"@type": "MedicalCode",
"code": "D013929",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Yoshiya Ito",
"url": "https://questionsmedicales.fr/author/Yoshiya%20Ito",
"affiliation": {
"@type": "Organization",
"name": "Department of Molecular Pharmacology, Graduate School of Medical Sciences, Kitasato University, Sagamihara, Kanagawa 252-0374, Japan; Department of Pharmacology, Kitasato University School of Medicine, Sagamihara, Kanagawa 252-0374, Japan."
}
},
{
"@type": "Person",
"name": "Masataka Majima",
"url": "https://questionsmedicales.fr/author/Masataka%20Majima",
"affiliation": {
"@type": "Organization",
"name": "Department of Molecular Pharmacology, Graduate School of Medical Sciences, Kitasato University, Sagamihara, Kanagawa 252-0374, Japan; Department of Pharmacology, Kitasato University School of Medicine, Sagamihara, Kanagawa 252-0374, Japan. Electronic address: mmajima@med.kitasto-u.ac.jp."
}
},
{
"@type": "Person",
"name": "Robert Eckenstaler",
"url": "https://questionsmedicales.fr/author/Robert%20Eckenstaler",
"affiliation": {
"@type": "Organization",
"name": "Martin-Luther-University Halle-Wittenberg, Department of Clinical Pharmacy and Pharmacotherapy, Halle (Saale), Germany."
}
},
{
"@type": "Person",
"name": "Anne Ripperger",
"url": "https://questionsmedicales.fr/author/Anne%20Ripperger",
"affiliation": {
"@type": "Organization",
"name": "Martin-Luther-University Halle-Wittenberg, Department of Clinical Pharmacy and Pharmacotherapy, Halle (Saale), Germany."
}
},
{
"@type": "Person",
"name": "Michael Hauke",
"url": "https://questionsmedicales.fr/author/Michael%20Hauke",
"affiliation": {
"@type": "Organization",
"name": "Martin-Luther-University Halle-Wittenberg, Department of Clinical Pharmacy and Pharmacotherapy, Halle (Saale), Germany."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Establishment of 11-dehydro-thromboxane B2 time-resolved immunoassay and application in membranous nephropathy.",
"datePublished": "2023-07-23",
"url": "https://questionsmedicales.fr/article/37488002",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.ab.2023.115252"
}
},
{
"@type": "ScholarlyArticle",
"name": "Dietary inflammation index association with serum levels of nitric oxide, prostacyclin, and thromboxane B2 among prinzmetal angina patients and healthy persons.",
"datePublished": "2023-12-02",
"url": "https://questionsmedicales.fr/article/38233271",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.numecd.2023.11.018"
}
},
{
"@type": "ScholarlyArticle",
"name": "Thromboxane A",
"datePublished": "2024-03-09",
"url": "https://questionsmedicales.fr/article/38460156",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/advs.202307926"
}
},
{
"@type": "ScholarlyArticle",
"name": "Difluorinated thromboxane A",
"datePublished": "2024-06-05",
"url": "https://questionsmedicales.fr/article/38840293",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1111/bph.16435"
}
},
{
"@type": "ScholarlyArticle",
"name": "Deletion of vascular thromboxane A",
"datePublished": "2023-11-17",
"url": "https://questionsmedicales.fr/article/37979705",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.bcp.2023.115916"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Lipides",
"item": "https://questionsmedicales.fr/mesh/D008055"
},
{
"@type": "ListItem",
"position": 3,
"name": "Acides gras",
"item": "https://questionsmedicales.fr/mesh/D005227"
},
{
"@type": "ListItem",
"position": 4,
"name": "Acides gras insaturés",
"item": "https://questionsmedicales.fr/mesh/D005231"
},
{
"@type": "ListItem",
"position": 5,
"name": "Acides gras indispensables",
"item": "https://questionsmedicales.fr/mesh/D005228"
},
{
"@type": "ListItem",
"position": 6,
"name": "Acides arachidoniques",
"item": "https://questionsmedicales.fr/mesh/D001095"
},
{
"@type": "ListItem",
"position": 7,
"name": "Thromboxanes",
"item": "https://questionsmedicales.fr/mesh/D013931"
},
{
"@type": "ListItem",
"position": 8,
"name": "Thromboxane B2",
"item": "https://questionsmedicales.fr/mesh/D013929"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Thromboxane B2 - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Thromboxane B2",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2026-05-09",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Thromboxane B2",
"description": "Comment mesurer le thromboxane B2 ?\nQuels tests sont utilisés pour le diagnostic ?\nLe thromboxane B2 est-il un biomarqueur ?\nQuels symptômes indiquent un test de thromboxane B2 ?\nLe thromboxane B2 est-il lié à des maladies spécifiques ?",
"url": "https://questionsmedicales.fr/mesh/D013929#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Thromboxane B2",
"description": "Quels symptômes sont liés à un excès de thromboxane B2 ?\nLe thromboxane B2 cause-t-il des symptômes ?\nComment le thromboxane B2 affecte-t-il la circulation ?\nQuels signes indiquent une agrégation plaquettaire excessive ?\nLe thromboxane B2 est-il impliqué dans des douleurs ?",
"url": "https://questionsmedicales.fr/mesh/D013929#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Thromboxane B2",
"description": "Comment prévenir l'augmentation du thromboxane B2 ?\nLe contrôle du stress aide-t-il à réduire le thromboxane B2 ?\nLes examens réguliers sont-ils importants ?\nL'hydratation influence-t-elle le thromboxane B2 ?\nLes habitudes alimentaires affectent-elles le thromboxane B2 ?",
"url": "https://questionsmedicales.fr/mesh/D013929#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Thromboxane B2",
"description": "Quels médicaments ciblent le thromboxane B2 ?\nComment réduire le thromboxane B2 ?\nLe traitement du thromboxane B2 est-il préventif ?\nQuels effets secondaires des traitements du thromboxane B2 ?\nLe thromboxane B2 nécessite-t-il un suivi médical ?",
"url": "https://questionsmedicales.fr/mesh/D013929#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Thromboxane B2",
"description": "Quelles complications sont liées à un excès de thromboxane B2 ?\nLe thromboxane B2 peut-il causer des maladies cardiaques ?\nComment le thromboxane B2 influence-t-il les AVC ?\nLe thromboxane B2 est-il lié à des complications chirurgicales ?\nQuelles sont les conséquences d'un traitement inapproprié ?",
"url": "https://questionsmedicales.fr/mesh/D013929#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Thromboxane B2",
"description": "Quels sont les facteurs de risque du thromboxane B2 ?\nL'âge influence-t-il le niveau de thromboxane B2 ?\nLe mode de vie affecte-t-il le thromboxane B2 ?\nLe stress est-il un facteur de risque ?\nLes antécédents familiaux jouent-ils un rôle ?",
"url": "https://questionsmedicales.fr/mesh/D013929#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment mesurer le thromboxane B2 ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le thromboxane B2 est mesuré par des tests sanguins spécifiques, souvent en laboratoire."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour le diagnostic ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests d'agrégation plaquettaire et des dosages de thromboxane B2 sont utilisés."
}
},
{
"@type": "Question",
"name": "Le thromboxane B2 est-il un biomarqueur ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, il peut servir de biomarqueur pour des troubles cardiovasculaires."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent un test de thromboxane B2 ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes de troubles de la coagulation ou des maladies cardiovasculaires peuvent indiquer un test."
}
},
{
"@type": "Question",
"name": "Le thromboxane B2 est-il lié à des maladies spécifiques ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, il est souvent associé à des maladies cardiovasculaires et à des troubles thromboemboliques."
}
},
{
"@type": "Question",
"name": "Quels symptômes sont liés à un excès de thromboxane B2 ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un excès peut provoquer des douleurs thoraciques, des crises cardiaques ou des AVC."
}
},
{
"@type": "Question",
"name": "Le thromboxane B2 cause-t-il des symptômes ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il ne cause pas de symptômes directement, mais son augmentation est liée à des conditions pathologiques."
}
},
{
"@type": "Question",
"name": "Comment le thromboxane B2 affecte-t-il la circulation ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il provoque une vasoconstriction, ce qui peut réduire le flux sanguin et causer des douleurs."
}
},
{
"@type": "Question",
"name": "Quels signes indiquent une agrégation plaquettaire excessive ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des ecchymoses fréquentes, des saignements ou des douleurs peuvent indiquer une agrégation excessive."
}
},
{
"@type": "Question",
"name": "Le thromboxane B2 est-il impliqué dans des douleurs ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, il peut contribuer à des douleurs liées à des événements thromboemboliques."
}
},
{
"@type": "Question",
"name": "Comment prévenir l'augmentation du thromboxane B2 ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation saine, l'exercice régulier et l'arrêt du tabac peuvent aider à prévenir son augmentation."
}
},
{
"@type": "Question",
"name": "Le contrôle du stress aide-t-il à réduire le thromboxane B2 ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la gestion du stress peut contribuer à réduire les niveaux de thromboxane B2."
}
},
{
"@type": "Question",
"name": "Les examens réguliers sont-ils importants ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des examens réguliers peuvent aider à détecter des problèmes liés au thromboxane B2."
}
},
{
"@type": "Question",
"name": "L'hydratation influence-t-elle le thromboxane B2 ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une bonne hydratation peut aider à maintenir une circulation sanguine saine et réduire les risques."
}
},
{
"@type": "Question",
"name": "Les habitudes alimentaires affectent-elles le thromboxane B2 ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une alimentation riche en oméga-3 peut aider à réduire les niveaux de thromboxane B2."
}
},
{
"@type": "Question",
"name": "Quels médicaments ciblent le thromboxane B2 ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les anti-inflammatoires non stéroïdiens (AINS) et les inhibiteurs de la thromboxane sont utilisés."
}
},
{
"@type": "Question",
"name": "Comment réduire le thromboxane B2 ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'utilisation d'aspirine et d'autres anticoagulants peut réduire sa production."
}
},
{
"@type": "Question",
"name": "Le traitement du thromboxane B2 est-il préventif ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, il peut être utilisé pour prévenir des événements cardiovasculaires chez les patients à risque."
}
},
{
"@type": "Question",
"name": "Quels effets secondaires des traitements du thromboxane B2 ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les effets secondaires peuvent inclure des saignements, des ulcères gastriques et des réactions allergiques."
}
},
{
"@type": "Question",
"name": "Le thromboxane B2 nécessite-t-il un suivi médical ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un suivi est essentiel pour ajuster le traitement et surveiller les effets."
}
},
{
"@type": "Question",
"name": "Quelles complications sont liées à un excès de thromboxane B2 ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications incluent des thromboses, des crises cardiaques et des AVC."
}
},
{
"@type": "Question",
"name": "Le thromboxane B2 peut-il causer des maladies cardiaques ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des niveaux élevés de thromboxane B2 sont associés à un risque accru de maladies cardiaques."
}
},
{
"@type": "Question",
"name": "Comment le thromboxane B2 influence-t-il les AVC ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il peut contribuer à la formation de caillots, augmentant le risque d'AVC ischémique."
}
},
{
"@type": "Question",
"name": "Le thromboxane B2 est-il lié à des complications chirurgicales ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un excès peut augmenter le risque de complications thromboemboliques après une chirurgie."
}
},
{
"@type": "Question",
"name": "Quelles sont les conséquences d'un traitement inapproprié ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un traitement inapproprié peut entraîner des saignements excessifs ou des événements thromboemboliques."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque du thromboxane B2 ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent l'hypertension, le tabagisme, l'obésité et le diabète."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il le niveau de thromboxane B2 ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le risque augmente avec l'âge, en raison de changements vasculaires et métaboliques."
}
},
{
"@type": "Question",
"name": "Le mode de vie affecte-t-il le thromboxane B2 ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un mode de vie sédentaire et une mauvaise alimentation augmentent les niveaux de thromboxane B2."
}
},
{
"@type": "Question",
"name": "Le stress est-il un facteur de risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress chronique peut augmenter les niveaux de thromboxane B2 et le risque cardiovasculaire."
}
},
{
"@type": "Question",
"name": "Les antécédents familiaux jouent-ils un rôle ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents familiaux de maladies cardiovasculaires augmentent le risque lié au thromboxane B2."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 31/03/2026
Contenu vérifié selon les dernières recommandations médicales
3 publications dans cette catégorie
Affiliations :
Department of Molecular Pharmacology, Graduate School of Medical Sciences, Kitasato University, Sagamihara, Kanagawa 252-0374, Japan; Department of Pharmacology, Kitasato University School of Medicine, Sagamihara, Kanagawa 252-0374, Japan.
Publications dans "Thromboxane B2" :
3 publications dans cette catégorie
Affiliations :
Department of Molecular Pharmacology, Graduate School of Medical Sciences, Kitasato University, Sagamihara, Kanagawa 252-0374, Japan; Department of Pharmacology, Kitasato University School of Medicine, Sagamihara, Kanagawa 252-0374, Japan. Electronic address: mmajima@med.kitasto-u.ac.jp.
Publications dans "Thromboxane B2" :
3 publications dans cette catégorie
Affiliations :
Martin-Luther-University Halle-Wittenberg, Department of Clinical Pharmacy and Pharmacotherapy, Halle (Saale), Germany.
Publications dans "Thromboxane B2" :
3 publications dans cette catégorie
Affiliations :
Martin-Luther-University Halle-Wittenberg, Department of Clinical Pharmacy and Pharmacotherapy, Halle (Saale), Germany.
Publications dans "Thromboxane B2" :
3 publications dans cette catégorie
Affiliations :
Martin-Luther-University Halle-Wittenberg, Department of Clinical Pharmacy and Pharmacotherapy, Halle (Saale), Germany.
Publications dans "Thromboxane B2" :
3 publications dans cette catégorie
Affiliations :
Martin-Luther-University Halle-Wittenberg, Department of Clinical Pharmacy and Pharmacotherapy, Halle (Saale), Germany.
Publications dans "Thromboxane B2" :
3 publications dans cette catégorie
Affiliations :
Institute of Clinical Pharmacology and Toxicology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Publications dans "Thromboxane B2" :
3 publications dans cette catégorie
Affiliations :
Martin-Luther-University Halle-Wittenberg, Department of Clinical Pharmacy and Pharmacotherapy, Halle (Saale), Germany. Electronic address: ralf.benndorf@pharmazie.uni-halle.de.
Publications dans "Thromboxane B2" :
3 publications dans cette catégorie
Affiliations :
Department of Kinesiology, Kansas State University, Manhattan, Kansas.
Publications dans "Thromboxane B2" :
3 publications dans cette catégorie
Affiliations :
Department of Kinesiology, Kansas State University, Manhattan, Kansas.
Publications dans "Thromboxane B2" :
3 publications dans cette catégorie
Affiliations :
Department of Kinesiology, Kansas State University, Manhattan, Kansas.
Publications dans "Thromboxane B2" :
3 publications dans cette catégorie
Affiliations :
Department of Kinesiology, Kansas State University, Manhattan, Kansas.
Publications dans "Thromboxane B2" :
3 publications dans cette catégorie
Affiliations :
School of Food Science and Technology, Jiangnan University, Wuxi 214122, China; State Key Laboratory of Food Science and Technology, Jiangnan University, Wuxi 214122, China.
Publications dans "Thromboxane B2" :
3 publications dans cette catégorie
Affiliations :
School of Food Science and Technology, Jiangnan University, Wuxi 214122, China; State Key Laboratory of Food Science and Technology, Jiangnan University, Wuxi 214122, China.
Publications dans "Thromboxane B2" :
3 publications dans cette catégorie
Affiliations :
School of Food Science and Technology, Jiangnan University, Wuxi 214122, China; State Key Laboratory of Food Science and Technology, Jiangnan University, Wuxi 214122, China.
Publications dans "Thromboxane B2" :
3 publications dans cette catégorie
Affiliations :
School of Food Science and Technology, Jiangnan University, Wuxi 214122, China; State Key Laboratory of Food Science and Technology, Jiangnan University, Wuxi 214122, China. Electronic address: liht@jiangnan.edu.cn.
Publications dans "Thromboxane B2" :
3 publications dans cette catégorie
Affiliations :
School of Food Science and Technology, Jiangnan University, Wuxi 214122, China; State Key Laboratory of Food Science and Technology, Jiangnan University, Wuxi 214122, China. Electronic address: weichen@jiangnan.edu.cn.
Publications dans "Thromboxane B2" :
3 publications dans cette catégorie
Affiliations :
School of Chemistry, University of Bristol, Bristol, UK.
Publications dans "Thromboxane B2" :
3 publications dans cette catégorie
Affiliations :
School of Chemistry, University of Bristol, Bristol, UK.
Publications dans "Thromboxane B2" :
2 publications dans cette catégorie
Affiliations :
Institute of Cardiovascular Disease.
Publications dans "Thromboxane B2" :
11-Dehydro-thromboxane B2 (11-dehydro-TXB2) is the final stable metabolite of thromboxane A2 (TXA2) and is involved in thrombus formation. Patients with membranous nephropathy (MN) are prone to thromb...
Time-resolved fluorescence immunoassay (TRFIA) for 11-dehydro-TXB2 was established by indirect competitive method. The coated 11-dehydro-TXB2-BSA conjugate was used to bind the 11-dehydro-TXB2 antibod...
The linear range of TRFIA was 16.38-2000 pg/mL, the sensitivity was 4.70 pg/mL, the average coefficients of variation from intra-assay and inter-assay were 3.50% and 4.95%, respectively, and the recov...
This study successfully established a new highly sensitive method for the detection of 11-dehydro-TXB2 in serum. 11-Dehydro-TXB2 has great potential in evaluating the risk of thromboembolic events in ...
This study aimed to assess the association between dietary inflammation index with serum Nitric oxide, Prostacyclin, and Thromboxane B2 among Prinzmetal angina patients and healthy persons....
This case-control study was conducted among 120 Prinzmetal angina patients and 120 healthy persons referred to the Ardabil Imam Khomeini Hospital between 2021 and 2022. Blood samples were gained from ...
In Prinzmetal angina patients, more dietary inflammation index can increase the serum Thromboxane B2 and decrease the serum Nitric oxide and Prostacyclin. More clinical trial study is needed to confir...
Prostanoids are endogenous lipid bioactive mediators that play essential roles in physiological processes such as glucocorticoid secretion. Here, it is found that the thromboxane (Tx)A...
Thromboxane A...
Platelet functional and signalling responses were studied using aggregometry, Ca...
BRET studies revealed that F-TXA...
F-TXA...
Pelacarsen decreases plasma levels of lipoprotein(a) [Lp(a)] and oxidized phospholipids (OxPL). It was previously reported that pelacarsen does not affect the platelet count. We now report the effect ...
Subjects with established cardiovascular disease and screening Lp(a) levels ≥60 mg per deciliter (~ ≥150 nmol/L) were randomized to receive pelacarsen (20, 40, or 60 mg every 4 weeks; 20 mg every 2 we...
Of the 286 subjects randomized, 275 had either an ARU or PRU test, 159 (57.8%) were on aspirin alone and 94 (34.2%) subjects were on dual anti-platelet therapy. As expected, the baseline ARU and PRU w...
Pelacarsen does not modify on-treatment platelet reactivity through the thromboxane A...
An effective method was developed for preparing galloylated procyanidins (GPCs) using galloyl-attached nucleophilic degradation. Under degradation conditions optimized through Box-Behnken design and s...
Cyclosporin A, an immunosuppressive agent, is extensively utilized for the prevention of transplant rejection and treat autoimmune disease in the clinic, despite its association with a high risk of hy...
Thromboxane (TX) A2, released by activated platelets, plays an important role in atherothrombosis. Urinary 11-dehydro-TXB2 (U-TXM), a stable metabolite reflecting the whole-body TXA2 biosynthesis, is ...
The U-TXM was measured pre-randomization to aspirin or placebo in 5948 people with type 1 or 2 diabetes and no cardiovascular disease, in the ASCEND trial. Associations between log U-TXM and SVE-R (n ...
Higher U-TXM was associated with older age, female sex, current smoking, type 2 diabetes, higher body size, urinary albumin/creatinine ratio of ≥3 mg/mmol, and higher estimated glomerular filtration r...
The U-TXM was log-linearly independently associated with SVE-R in diabetes. This is consistent with the involvement of platelet TXA2 in diabetic atherothrombosis....
Urinary prostaglandin (PG) E metabolite (PGE-M) and 11-dehydro (d)-thromboxane (TX) B...